Darzalex IV
Daratumumab · Injection, Solution, Concentrate · Intravenous
No FDA structured label text is available for Darzalex IV. The NDC listings below come from the FDA National Drug Code directory.
Active ingredients
- Daratumumab in 1 product
Darzalex IV NDC products (1)
| NDC | Strength & form | Labeler | Type |
|---|---|---|---|
| 57894-505 | Daratumumab 100 mg/5mL Injection, Solution, Concentrate | Janssen Biotech, Inc. | BLA |
Frequently asked questions
Who makes Darzalex IV?
Darzalex IV is listed by 1 labeler in the FDA NDC directory, including Janssen Biotech, Inc..